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After the passage of the 2018 Farm Bill, champions of hemp 
began to tout opportunities for farmers and businesses involved with 
the crop.  The industry has rallied around one of hemp’s major 
byproducts, cannabidiol, or CBD.  However, the demand for CBD 
has left the Food and Drug Administration (“FDA”) playing catch-
up.  This article explains what CBD is, how it is derived, current 
FDA-approved uses, and a current path forward for the FDA in 
creating guidance for industry and consumers. 
I.  Introduction  
It is difficult today to read the news, browse social media, or 
even shop in some stores without encountering people extolling the 
virtues of cannabidiol (“CBD”) or questioning its therapeutic value.2  
The Food and Drug Administration has been challenged by the 
proliferation of CBD in many markets.  The hype has not escaped the 
FDA’s notice, but a federal agency is not poised to quickly respond 
to trends like these, therefore, the agency has yet to promulgate a full 
set of regulations.   
The production and use of CBD involve competing interests, 
from the pharmaceutical sector, food producers, farmers, and 
consumers.  Each of these parties has an interest in regulations being 
developed sooner rather than later, in part because there is currently 
significant market opportunity for CBD products.  This article 
explores the following issues relating to CBD: what CBD is; how it 
is different from other cannabis products; what CBD is being used 
for; and how the federal government can appropriately regulate the 
production and use of the product.  Due to the limited existing 
research on the effects of CBD, the best option may be for the FDA 
 
* Hannah Catt holds a J.D. with certificates in Environmental and Health Law from 
the University of Maryland Francis King Carey School of Law, as well as an LL.M. 
in Agricultural & Food Law from the University of Arkansas School of Law.  
1 Some companies that market CBD products are mentioned by name in this article.  
No mention of a specific company serves as an endorsement; it is purely for 
illustrative purposes.   
2 See, e.g., Alex Williams, Why is CBD Everywhere?, N.Y. TIMES (Oct. 7, 2018), 
https://www.nytimes.com/2018/10/27/style/cbd-benefits.html. 




to allow CBD to be sold as a supplement in limited concentrations 
while also working towards new drug approvals.     
II.  Hemp and Cannabinoids  
In recent years, many states have legalized medicinal and/or 
recreational marijuana use.3  Recent legislation expanding programs 
for legal hemp production has increased interest in by-products of 
the plant beyond traditional, industrial uses.4  Despite the differences 
in the use and availability of marijuana and hemp, the two are 
inextricably linked, usually under the banner of “cannabis.”  While 
confusing, this is not a mistake.  Marijuana and hemp are both 
products of Cannabis sativa, however, they are distinguishable based 
on their relative concentration of tetrahydrocannabinol (“THC”).5  
The plants can also be distinguished by their physical features when 
growing, as explained in Section II.   
Marijuana is often consumed for the psychoactive effects of 
THC, which is present in varying amounts based on the plant variety 
or cultivar.6  CBD is commonly considered non-psychoactive 
because it does not produce the “high” associated with consuming 
marijuana.7  In his work, prominent cannabis researcher Dr. Ernest 
Small has clarified that this common usage of the term non-
psychoactive for describing CBD is not proper because any 
significant change in mental state, including anxiety changes, should 
be considered a psychoactive effect.8   
CBD and THC are also both cannabinoids, a chemical 
component of the cannabis sativa plant.9  While cannabinoids have 
been found in other plants, CBD is noted as the “principal 
cannabinoid of hemp.”10  There have been over 100 cannabinoids 
identified in cannabis.11  The cannabinoids act by binding to 
 
3 NAT’L CONF. OF STATE LEGISLATURES, MARIJUANA OVERVIEW (2019), 
http://www.ncsl.org/research/civil-and-criminal-justice/marijuana-overview.aspx.  
4 7 U.S.C. § 5940 (2018).  
5 CONG. RES. SERV., Defining Hemp: A Fact Sheet 1 (March 22, 2019), https://fas.org 
/sgp/crs/misc/R44742.pdf. 
6 Variety is technically used to note the plant types that are found in nature, while 
cultivars are bred for specific characteristics. Id. (citing Cindy Haynes, Cultivar 
Versus Variety, IOWA ST. UNIV. HORTICULTURE & HOME PEST NEWS (Feb. 6, 2008), 
https://hortnews.extension.iastate.edu/2008/2-6/CultivarOrVariety.html).   
7 ERNEST SMALL, CANNABIS: A COMPLETE GUIDE 204 (2016). 
8 Id.   
9 Id. at 205. 
10 Id. 
11 Genevieve Lafaye, et al., Cannabis, Cannabinoids, and Health, 19 DIALOGUES IN 
CLINICAL NEUROSCIENCE 3, 309 (2017). 
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receptors in the body’s endocannabinoid system.12  This system and 
the resulting effects of cannabinoids in the body were not discovered 
until the late twentieth century.13   
CB1 and CB2 are both found in the central nervous system 
and various organs throughout the body.14  Because of the relatively 
recent discovery of the endocannabinoid system and the many 
restrictions around research related to cannabis, a full understanding 
of the effects of cannabinoids is still developing.  The different 
receptor locations where the binding takes place can impact the 
ultimate effects of cannabis consumption, the potency of the product, 
and how CBD and THC will impact the body.15 
An additional area of study is how different cannabinoids 
work together.  Those involved in the illicit trade or consumption of 
marijuana are seeking out a higher THC content, which will increase 
the psychoactive effects.  New strains of cannabis have been bred to 
have a higher THC content at the expense of the CBD content.  In 
the reverse, cannabis bred for fiber or oilseed has high CBD content 
and minimal THC.16  Further, manufacturers of marijuana edibles do 
not currently have an incentive to add CBD to the final product.17  
This may change as more is discovered about the combined effects 
of THC and CBD, referred to as “entourage” or “ensemble” effects.18  
Consumption of THC and CBD has been shown to lessen some of 
the psychoactive symptoms of THC.19  The reason for this is not 
immediately clear, but researchers have noticed this in patients who 
take approved drugs with THC, such as Marinol, an appetite 
stimulant primarily prescribed for patients with AIDS.20 
CBD is produced through an extraction process which 
should be highly monitored to ensure there is no THC present.  To 
 
12 Pál Pacher, et al., The Endocannabinoid System as an Emerging Target of 
Pharmacotherapy, 58 PHARMACOL REV. 3, 389 (2006). 
13 Matt Simon, THC! CBD! Terpenoids! Cannabis Science is Getting Hairy, WIRED 
(Nov. 6, 2018), https://www.wired.com/story/cannabis-science-entourage-effect/. 
14 Id.    
15 SMALL, supra note 7, at 304–06. 
16 Id. at 208. 
17 Simon, supra note 13. 
18 Some researchers prefer the term “ensemble effect” because it does not suggest 
that THC is the most important cannabinoid for the endocannabinoid system 
response.  Simon, supra note 13. 
19 Ethan B. Russo, Taming THC: Potential Cannabis Synergy and Phtocannabinoid 
Terpenoid Entourage Effects, 163 BRIT. J. PHARMACOLOGY 1344, 1354 (2011). 
20 Simon, supra note 13; Pácher, et al., supra note 12, at Table 1 (reporting that 
patients taking Marinol experienced improvement in the areas of “spasticity, pain, 
and sleep quality” and “was found to suppress otherwise intractable cholestatic 
pruritus in a case report”).  




extract the CBD, hemp plants are harvested and then left to cure for 
a few weeks.21  The flower of the plant is then removed and sent to a 
processor.22  The processor grinds the flowers, then steeps them to 
remove some terpenoids.23  After a cold treatment, it is distilled, 
sometimes twice, to achieve the right color and purity.24  Many 
brands have their products tested to guarantee purity and low or no 
THC content.25 
III.  Examining Hemp Production  
The revenue that states and businesses have generated from 
selling recreational marijuana is frequently labeled as a “Green 
Rush.”26  The value of the CBD market could be a second wave in 
this rush because it is worth around half a billion dollars today and 
has the potential to reach twenty billion dollars by 2020.27  However, 
hemp has a long history of use for other industrial purposes and has 
proven to be a versatile crop.28  Hemp uses less inputs than a more 
traditional crop like corn.29  Once out of the initial development time, 
producers use less water, pesticides, and fertilizers.30  The terpenoids 
 
21 Eric Hurlock, Harvesting, Drying, Trimming, & Curing Industrial Hemp Flower, 
LANCASTER FARMING (Sep. 3, 2019), https://www.lancasterfarming.com (search 
article name) (discussing measures a farm takes to monitor CBD and THC levels in 
hemp flowers prior to harvest); Rajul Punjabi, There’s CBD in Everything so We 
Found Out How It’s Made, VICE (Oct. 23, 2018), http://www.vice.com/en_us/article 
/wj9knb/i-visited-a-cannabis-farm-to-find-out-how-cbd-oil-is-made. 
22 Punjabi, supra note 21. 
23 Id. 
24 Id.  
25 Medterra is an example of this.  This company sources all of its hemp from 
products grown as a part of the Kentucky Department of Agriculture Pilot Program.  
Frequently Asked Questions, MEDTERRA, https://medterracbd.com/faq (last visited 
Nov. 9, 2019) (linking interested consumers to the third-party lab test results of the 
company’s CBD products). 
26 See, e.g., Nick Kovacevich, Green Rush: How Legal Hemp Opens the Door for 
Cannabis Investment, FORBES (Aug. 8, 2019), https://www.forbes.com (search 
article title). 
27 Brian Barth, The Rise and Rise of the Artisanal Hemp Farm. From Seed-to-CBD, 
Our Writer Doses Up Then Files This Report, MODERN FARMER (Feb. 25, 2019), 
https://modernfarmer.com/2019/02/the-rise-and-rise-of-the-artisanal-hemp-farm-fr 
om-seed-to-cbd-our-writer-doses-up-then-files-this-report/. 
28 Ernest Small & David Marcus, Hemp: A New Crop with New Uses for North 
America, in TRENDS IN NEW CROPS AND NEW USES 284-326 (J. Janick & A Whipkey 
eds., 2002), https://www.hort.purdue.edu/newcrop/ncnu02/v5-284.html (describing 
some of the historical uses of hemp in industry). 
29 Logan Yonavjak, Industrial Hemp: A Win-Win For the Economy and the 
Environment, FORBES (May 29, 2013), https://www.forbes.com/ (search “Industrial 
Hemp Win Win” and select the first result); Brian Barth, So, You Want to Be a Hemp 
Farmer?, MODERN FARMER (July 9, 2018), https://www.modernfarmer.com/2018/0 
7/so-you-want-to-be-a-hemp-farmer/. 
30 Id. 
78               JOURNAL OF FOOD LAW & POLICY                 [Vol.15 
that give cannabis its unique smell have also been found in other 
plants as a method of insect deterrent.31  Hemp plants grow tall, 
occasionally up to sixteen feet.32  Plant height is one way to easily 
distinguish hemp from marijuana, with the latter usually being short 
and stubby.33  
Once harvested, hemp can be made into almost 25,000 
different products in categories including: textiles, automotive parts, 
food and beverages, and personal care products.34  Most of the hemp 
going into these products had to be imported though, due to 
restrictions on growing hemp.35  China accounts for the largest share 
of production, growing roughly one-fifth of the world supply and 
importing the most to the United States (“U.S.”).36  Hemp fiber and 
seeds can have returns of up to $700 per acre or $1,200 per acre, 
respectively.37  The total market value is approaching one billion 
dollars.38  The opportunity to grow hemp for use in American 
industry and processing is an attractive one, and it presents a valuable 
market opportunity for potential hemp farmers.39  The history of 
hemp production shows that there are many uses for the crop beyond 
focusing exclusively on CBD.  The CBD market could collapse at 
any time or be severely restricted if the FDA takes a more aggressive 
stance on non-prescribed uses of the compound.   
    China has historically produced large volumes of hemp, and 
evidence suggests that they have been growing it for anywhere from 
six to ten thousand years.40  Hemp was spread from China to Western 
Asia and Egypt, and then to Europe.41  The crop did not arrive in 
North America until the seventeenth century.42  From approximately 
that time until the nineteenth century, hemp was at its peak, being 
used for textiles, paper, and even sails for ships.43  Many reasons are 
suggested for its decline in popularity, including the labor involved 
 
31 Russo, supra note 19, at 349. 
32 Cheryl Thayer et al., Industrial Hemp: From Seed to Market, HARVEST N.Y., 
(2017), http://putknowledgetowork.org/resources/industrial-hemp-from-seed-to-ma 
rket. 
33 Id.   
34 Id.   
35 Id.   
36 Id.   
37 CONG. RES. SERV., supra note 5, at 8.  
38 The U.S. Hemp Industry Grows to $820mm in Sales in 2017, HEMP BUS. J., (2017), 
hempbizjournal.com/size-of-us-hemp-industry-2017/. 
39 Comparing it to grain, Brian Barth asserts that fifty acres should be a minimum 
for growing hemp to retain profitability.  Barth, supra note 29. 
40 SMALL, supra note 7, at 91. 
41 Id. at 92. 
42 Id. 
43 Id. at 93–94. 




with cultivation, cheaper fibers becoming available during the 
Industrial Revolution, and the decreased use of sailing ships in favor 
of fuel-powered ships.44   
Until the 2014 Farm Bill hemp provisions, hemp was 
regulated along with marijuana.45  Hemp was listed as a Schedule I 
substance under the Controlled Substances Act (“CSA”), and the 
Drug Enforcement Administration (“DEA”) provided oversight.46  
This classification required anyone who wanted to grow hemp to get 
approval from the DEA, but applications were usually not 
approved.47  One early university research plot was approved in 
North Dakota, but it involved significant costs.48  Similar to states 
choosing to allow recreational marijuana consumption while it is 
restricted federally, states could create their own policies to allow 
hemp cultivation if a DEA license was granted.      
Hemp provisions found in the 2014 Farm Bill created an 
agricultural pilot program “to study the growth, cultivation, or 
marketing of industrial hemp.”49  While states are allowed to create 
their own regulations for programs, growing sites have to be 
registered with and certified by the state’s department of agriculture, 
and the growing is limited to research purposes of agriculture 
departments or colleges and universities.50  “Industrial hemp” is 
defined as cannabis sativa with less than 0.3% THC on a dry weight 
basis.51  This figure is widely used to distinguish hemp from 
marijuana.  The THC amount was proposed by Ernest Small, who 
indicated that, at 1% THC presence, marijuana begins to have 
“intoxicating potential.”52  In addition to the U.S., Canada and 
portions of Europe and Australia use the same threshold.53  Small is 
quick to note this is a low threshold but contends that this makes it 
 
44 Id. at 94. 
45 CONG. RES. SERV., supra note 5, at 3–4. 
46 21 U.S.C § 812 (b)(1) (2018) (providing that Schedule I substances have “a high 
potential for abuse,” “no currently accepted medical use in treatment in the United 
States,” and a “lack of accepted safety for use of the drug or other substance under 
medical supervision.”) 
47 Christine A. Kolosov, Evaluating the Public Interest: Regulation of Industrial 
Hemp Under the Controlled Substances Act, 57 UCLA L. REV. 237, 247 (2009) 
(providing an overview of the legal status of hemp cultivation over time in the U.S. 
and explaining how state programs to allow cultivation are limited by DEA 
approval).   
48 Id. 
49 7 U.S.C. § 5940.   
50 Id. § 5940(A)–(B).   
51 Id.  
52 SMALL, supra note 7, at 208. 
53 Id. 
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highly unlikely that hemp would be repurposed for illegal 
consumption.54   
 The 2018 Farm Bill loosened the restrictions on hemp 
further, officially removing it from the federal schedule of controlled 
substances.55  Because it was removed from the schedule, the DEA 
also cannot interfere with the passage of hemp across state lines.56  
Growers still have to operate under a state pilot program, of which 
there are currently forty-one.57   
Kentucky was an early leader in the U.S. hemp market after 
pilot program rules were released in the 2014 Farm Bill.  State law 
requires producers, handlers, processers, and marketers to obtain a 
license from the Kentucky Department of Agriculture.58  Violation 
of the licensing requirements is penalized by the same provisions for 
violations of state rules relating to marijuana.59  These penalties are 
found in state statutes for controlled substances.60  The state 
publishes a list of licensees, which can help facilitate the market for 
hemp.61  There are over one hundred processors and handlers 
licensed, and, in 2018, farmers were paid over $17 million for hemp, 
and over $50 million of gross products were sold.62  The acreage in 
use is also rapidly increasing, approaching 10,000 acres.63  Kentucky 
Commissioner of Agriculture Ryan Quarles has noted that these 
 
54 Id. 
55 KY. DEP’T OF AGRIC., 2018 FARM BILL AND WHAT IT MEANS FOR HEMP IN 
KENTUCKY (2018), http://www.kyagr.com/marketing/program_id/70/documents/H 
EMP_OV_2018FarmBillandKentuckyHemp.pdf. 
56 Id.  
57 INDIGENOUS FOOD & AGRIC. INITIATIVE, THE 2018 FARM BILL AND THE LEGAL 
LANDSCAPE FOR INDUSTRIAL HEMP PRODUCTION IN INDIAN COUNTRY 3, UNIV. OF 
ARK. (2019), https://static1.squarespace.com/static/5aaaa2bd4611a0a9a6f8353d/t/5 
c996196104c7b647468f5da/1553555912189/Final+IFAI+Hemp+Analysis.pdf 
(showing that the nine states that still outlaw hemp are Idaho, Georgia, South 
Dakota, Texas, Iowa, Louisiana, Mississippi, Ohio, and Connecticut); Fran Howard, 
Hemp Producers Stuck Somewhere Between Two Farm Bills, AGRI PULSE (April 17, 
2019), https://www.agri-pulse.com/articles/12104-regulatory-confusion-leaves-he 
mp-producers-stuck-somewhere-between-two-farm-bills. 
58 INDUSTRIAL HEMP RESEARCH PILOT OVERVIEW, KY. DEP’T OF AGRIC., 
https://www.kyagr.com/marketing/hemp-overview.html (last visited Nov. 27, 
2019). 
59 HEMP AND THE LAW, KY. DEP’T OF AGRIC., https://www.kyagr.com/marketing/he 
mp-law.html (last visited Nov. 27, 2019). 
60 KY. REV. STAT. ANN. § 218A.140 (West 2011). 
61 2018 LICENSE HOLDER LIST (2018), KY. DEP’T OF AGRIC., https://www.kyagr.com/ 
marketing/documents/HEMP_OV_License-Holder-List_2018.pdf. 
62 Bruce Schreiner, Hemp is Growing Like Crazy in Kentucky.  Just Look at Last 








figures represent a small portion of the state’s total agricultural 
production, but the program’s goal was to ensure that Kentucky 
could gain a lead on the market when it became legal to start 
production and interstate transport.64  
The hemp provisions found in the 2018 Farm Bill have not 
yet been enacted by the United States Department of Agriculture 
(“USDA”).  Until enacted, the market needs to operate under the 
rules from the 2014 bill.  Growers have major questions about crop 
insurance, organic certification, interstate transportation, and 
banking access.65  Secretary of Agriculture Sonny Perdue estimated 
that there will not be rules in time for this season, but they will be 
ready for 2020 planting.66  Growers are also having trouble getting 
access to seeds to purchase, because they may have to be imported, 
and growers need to ensure they have varieties with THC levels 
below the legal threshold.67  
Due to the natural resilience of hemp, it is well-suited to 
organic growing methods.68  The USDA, which oversees the 
National Organic Program, has allowed organic certification for 
hemp, but not marijuana.69  Allowing organic certification for hemp 
byproducts like CBD could be beneficial, particularly if it is being 
utilized as an ingredient in pharmaceuticals.  Organic textiles are also 
specially marketed, often for clothing.70  Kentucky is home to the 
Kentucky Organic Hemp Cooperative, one of the country’s first, 
which has brought together farmers with smaller-than-usual acreage 
who want to get market access.71  Many of these farmers are growing 
on land that has not recently been used for conventional crops, so 
they do not have to wait through the three-year transitional period 
that conventional farms need for organic certification.72  Most of 
 
64 Id.  
65 Ryan McCrimmon, Washington Has Work to Do on CBD, Hemp, POLITICO (Feb. 
26, 2019), https://www.politico.com/newsletters/morning-agriculture/2019/02/27/ 
washington-has-work-to-do-on-cbd-hemp-526036. 
66 Ryan McCrimmon, Perdue, Senate Ag Talk Farm Bill Today, POLITICO (Feb. 28, 
2019), https://www.politico.com/newsletters/morning-agriculture/2019/02/28/perd 
ue-senate-ag-talk-farm-bill-today-528350. 
67 Howard, supra note 57. 
68 Seth Waggener, Organically Grown Hemp: Why Is It So Important?, PURE 
SPECTRUM (Feb. 8, 2018), https://www.purespectrumcbd.com/organically-grown-
hemp-why-is-it-so-important/. 
69 Barth, supra at note 29.   
70 Does Organic Fabric Really Make a Difference?, HYDE YOGA BLOG (Aug. 1, 
2019), https://yogahyde.com/yoga-wear-organic-vs-non-organic/. 
71 Austyn Gaffney, Kentucky Farmers Gamble on the South’s First Organic Hemp 
Cooperative, SOUTHERLY (Mar. 13, 2019), https://southerlymag.org/2019/03/13/ken 
tucky-farmers-gamble-on-the-souths-first-organic-hemp-cooperative/.   
72 Id. 
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them are also growing hemp that will have CBD extracted because 
as much as seventy percent of the state’s hemp is sold to the CBD 
market.73          
IV.  Current FDA Stance  
A.  Food, Drug, and Cosmetic Act Rules  
At its core, the primary concern with the regulation of CBD 
products is about consumer safety.  The FDA does not want the 
public taking products that have not been tested for purity or because 
a company has made a wild claim about CBD’s ability to cure an 
ailment.74  Concerns about the safety of food and drugs have existed 
since time immemorial, but the first major U.S. legislation on the 
subject was the 1906 Food and Drugs Act, passed by President 
Theodore Roosevelt.75  This Act cracked down on adulterated and 
misbranded food and drugs.76  The enactment was motivated by 
problems in the industry, including a 1902 tragedy in St. Louis, when 
thirteen children died after taking a contaminated drug.77  The 
children were administered a diphtheria antitoxin, but it was 
contaminated with tetanus spores.78   
The Act was updated under the administration of President 
Franklin Roosevelt, with the 1938 Federal Food, Drug, and Cosmetic 
Act (“FDCA”).79  Although the FDCA has been amended since its 
inception, it remains the key starting point for understanding food 
and drug regulation.   
 
73 Id.   
74 WHAT YOU NEED TO KNOW (AND WHAT WE’RE WORKING TO FIND OUT) ABOUT 
PRODUCTS CONTAINING CANNABIS OR CANNABIS-DERIVED COMPOUNDS, INCLUDING 
CBD, U.S. FOOD & DRUG ADMIN. (July 17, 2019), https://www.fda.gov/consumers/ 
consumer-updates/what-you-need-know-and-what-were-working-find-out-about-
products-containing-cannabis-or-cannabis. 
75 MILESTONES IN U.S. FOOD LAW, N.D. STATE UNIV., https://www.ag.ndsu.edu/food 
law/overview/history/milestones (last visited Dec.2, 2019). 
76 HOW DID THE FEDERAL FOOD, DRUG, AND COSMETIC ACT COME ABOUT, U.S. 
FOOD & DRUG ADMIN. (Mar. 28, 2018), https://www.fda.gov/about-fda/fda-basics/h 
ow-did-federal-food-drug-and-cosmetic-act-come-about. 
77 Linda Bren, The Road to the Biotech Revolution – Highlights of 100 Years of 
Biologics Regulation, FDA CONSUMER MAG. 1 (Jan.-Feb. 2016), https://www.fda.go 
v/files/about%20fda/published/The-Road-to-the-Biotech-Revolution--Highlights-o 
f-100-Years-of-Biologics-Regulation.pdf. 
78 PETER BARTON HUTT ET AL., FOOD & DRUG LAW 6–7 (Robert C. Clark et al. eds., 
4th ed. 2014).   
79 HISTORIES OF PRODUCT REGULATION: THE 1938 FOOD, DRUG, AND COSMETIC ACT, 
U.S. FOOD & DRUG ADMIN. (Jan. 31, 2019), https://www.fda.gov/about-fda/historie 
s-product-regulation/1938-food-drug-and-cosmetic-act. 




The FDCA defines drugs as “articles intended for use in the 
diagnosis, cure, mitigation, treatment, or prevention of disease in 
man or other animals and articles (other than food) intended to affect 
the structure or any function of the body of man or other animals.”80  
Before any drug can be sold, manufacturers submit an application to 
the FDA Center for Drug Evaluation and Research (CDER).81  New 
products are submitted under a new drug application; however, there 
are many other types of approval processes, including for 
investigational new drugs, therapeutic biologics, and over-the-
counter drugs.82  All of this application information will help the 
FDA make a decision about approved doses, potential interactions 
with other drugs, side effects that require warnings, and whether a 
drug can be used continuously.83  
Although the 2018 Farm Bill removed hemp from DEA 
oversight, it did not modify the FDA’s authority on cannabis 
products or compounds.84  Cannabis remains a Schedule I drug 
according to the DEA, indicating no accepted medical use.85  
However, the FDA has approved one cannabis-derived drug and 
three “cannabis-related” drugs.86  The only approved drug with CBD 
as an active ingredient is Epidiolex, and it was approved to treat 
seizures in children suffering from Lennox-Gastaut or Dravet 
syndrome.87  The cannabis-derived drugs rely on synthetic THC, 
either dronabinol or nabilone.  The drugs are Marinol, Syndros, and 
Cesamet.88  The first two have been useful in combatting appetite 
loss in AIDS patients.89  Cesamet was approved for chemotherapy 
patients to reduce nausea and vomiting from the treatment.90  
 
80 Federal Food, Drug, And Cosmetic Act, 21 U.S.C. § 321 (2016). 
81 HOW DRUGS ARE DEVELOPED AND APPROVED, U.S. FOOD & DRUG ADMIN. (Jan. 7, 
2019), https://www.fda.gov/drugs/development-approval-process-drugs/how-drugs 
-are-developed-and-approved. 
82 Id.   
83 Id.   
84 FDA REGULATION OF CANNABIS AND CANNABIS-DERIVED PRODUCTS: QUESTIONS 
AND ANSWERS, FOOD & DRUG ADMIN. (Apr. 2, 2019), https://www.fda.gov/news-
events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products 
-questions-and-answers [hereinafter U.S. FOOD & DRUG ADMIN., REGULATION OF 
CANNABIS]. 
85 Id.   
86 Id.   
87 Id.   
88 Id.   
89 Id. 
90 Valeant Pharmaceuticals, Cesamet FDA Application, U.S. FOOD & DRUG ADMIN. 
(May 2006), https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018677s0 
11lbl.pdf. 
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The trial conducted for epilepsy, which led to the approval 
of Epidiolex, was supported by the drug manufacturer GW 
Pharmaceuticals.91  This presents a challenge for drug development–
large pharmaceutical companies have significant resources to pour 
into research and development, go through the lengthy 
administrative process to get a drug approved by the FDA, and 
conduct testing to ensure they have a pure and safe product.  Once 
hemp research is less restricted, it is possible that these large 
companies may try to get in on the market for legal drugs first, 
capturing most of the revenue.  However, an increase in the number 
of approved hemp-derived drugs could create a stable market for 
farmers.92   
The FDA approval of CBD as an active ingredient in 
Epidiolex was a victory for the patients it will help.  The market for 
CBD supplements and food products was hindered, however, 
because of FDCA rules which restrict the use of active ingredients in 
FDA-approved drugs for food and dietary supplements.  A dietary 
supplement can contain an herb or botanical, but because it is an 
active ingredient in a drug, CBD cannot be marketed as a dietary 
supplement.93  The FDA does have the discretion to go through the 
notice and comment process to create a regulation allowing the sale 
of dietary supplements with an approved-drug active ingredient.94  
However, the FDA has not chosen to exercise that discretion at this 
time.95  
The same restriction outlaws the introduction of CBD-
containing products into interstate commerce.  Section 331 of the 
FDCA prohibits “[t]he introduction or delivery for introduction into 
interstate commerce of any food to which has been added a drug 
approved under section 355 of this title.”96  Similar to the rules on 
supplements, the FDA Secretary can use his discretion to issue a 
regulation that allows the use of the drug in food.97  There are already 
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foods derived from hemp, and some, like hempseed, are easy to 
find.98   
The interest in CBD for food products is not limited to 
humans, either.  Martha Stewart has formed a partnership with the 
Canadian company “Canopy Growth” to launch a line of pet products 
with CBD.99  Another celebrity getting in on the market is rock star 
Gene Simmons, who recently announced a CBD soda.100 There are 
many other edible products, topical products, and cosmetics that are 
available, creating a lot of work for anyone attempting to enforce the 
FDCA provisions, whether by preventing products from being 
shipped in interstate commerce or completely stopping their sale.101    
An additional and interesting component of the market for 
CBD products is how they move in commerce, either inter- or 
intrastate.  Earlier this year, the U.S. Postal Service (USPS) issued 
an advisory about the mailing of CBD products.102  Specifying that 
these rules are temporary until the 2018 Farm Bill can be fully 
implemented, the USPS is allowing shipment of CBD products under 
certain circumstances.103  In connection with the permitted research 
production of hemp, mailers have to sign a statement certifying that 
they have a valid license from the state department of agriculture in 
the mail piece’s originating state.104     
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The FDA has been proactive in releasing information about 
CBD and ensuring that the public can find and understand the 
agency’s position.  However, the momentum was stalled when FDA 
Commissioner Scott Gottlieb announced in March that he would be 
stepping down from his post in April.  Gottlieb surprised many 
people with his progressive work during his two years at the agency, 
and he commented frequently on CBD in particular.105  Because of 
the limits of agency rulemaking, he suggested that Congress make 
rules for the use of CBD in food products, because Congress could 
act more quickly.106  Gottlieb has since left the FDA, but the agency 
moved ahead with a public hearing on May 31, 2019, with the 
purpose to “obtain scientific data and information about the safety, 
manufacturing, product quality, marketing, labeling, and sale of 
products containing cannabis or cannabis-derived compounds.”107   
At the hearing, presentations were made on topics ranging 
from prescription interactions with cannabidiol to the use of hemp-
derived ingredients in animal feed.108  There were representatives 
from consumer groups, state departments of agriculture, and 
academia, among others.109  The breadth of representation is a good 
indication of the interest in creating regulations for cannabinoids and 
creating a path for researchers to understand them.  In a letter 
addressed to Ned Sharpless, the acting commissioner of the FDA 
after Gottlieb’s departure, a bipartisan group of Congressional 
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representatives addressed the issue of CBD in food products.110  They 
specifically proposed that the agency create an interim final rule for 
the use of CBD in food products and dietary supplements in addition 
to creating enforcement guidance and standards evaluating the safety 
and accuracy of labeling.111   
The agency rulemaking process has many layers and can 
seem quite complex, but every step is designed to ensure interested 
parties can make their voice heard and that the agency can gather 
appropriate technical information before promulgating a new rule.  
Agencies publish a proposed rule or Notice of Proposed Rulemaking 
(“NPRM”) in the Federal Register.112  Comment periods are typically 
thirty to sixty days, but can be longer if the rule is particularly 
complicated.113  The upcoming public meeting on CBD will allow 
people to share comments and information with the FDA, and the 
agency is also taking written comments.  A final rule should be based 
on the entire rulemaking record, including these public comments.  
Former Commissioner Gottlieb expanded on the potential of 
rulemaking for CBD in an interview with the Brookings Institution 
in March.114  He stated that a standard rule takes “two to three years,” 
and that he didn’t believe he could have accomplished rule formation 
during his tenure, nor will the person who succeeds him.115  Gottlieb 
considers a rule for CBD in food to be novel and complex, because 
it has already been used in a drug and was not previously approved 
for use in food.116  He also described the imminent creation of a 
workgroup that would consider methods for Congress to create a 
legal route, noting that this was done for human growth hormone and 
fish oil.117     
The FDA has less control over dietary supplements than it 
does over prescription drugs.  Premarket approval or notification to 
the FDA is limited, and the labeling rules are more expansive than 
 
110 See Letter from Cong. of the United States to Ned Sharpless, Acting Comm’r, 
U.S. Food & Drug Admin. 1 (Sept. 19, 2019), https://pingree.house.gov/uploadedfil 
es/pingree_comer_cbd_letter_to_fda_9.19.19.pdf.   
111 Id. at 2. 
112 A Guide to the Rulemaking Process, OFF. OF THE FED. REG.,  https://www.federalr 
egister.gov/uploads/2011/01/the_rulemaking_process.pdf. 
113 Id. 
114 Interview by Anna Edney with Scott Gottlieb, Former Comm’r, Food and Drug 





117 Id.   
88               JOURNAL OF FOOD LAW & POLICY                 [Vol.15 
those for prescription drugs.118  Presently, there are companies that 
market CBD and label it as supplements.119  Medterra, the company 
that sources hemp from Kentucky, labels its products as 
supplements.120  The company does list a disclaimer at the bottom of 
every web page that reads: “[r]epresentations regarding the efficacy 
and safety of Medterra have not been evaluated by the Food and Drug 
Administration. These products are not intended to diagnose, 
prevent, treat, or cure any disease.”121  This has not stopped many 
reviews from extolling the uses of the product for joint paint, anxiety, 
hearing loss, and other issues.122  The company ships to every state 
in the U.S. and internationally.   
Other companies advertising CBD supplements are easy to 
find.  The FDA has issued warning letters to numerous companies, 
most of them for making unsubstantiated therapeutic claims about 
the products for sale.123  Warning letters give businesses time to take 
corrective action before more serious consequences are imposed, 
including product seizures or injunctions to halt the sale of items.124   
At the local and state level, health departments are cutting 
into the sales of CBD in food.  The Los Angeles County Health 
Department issued its own guidance for restaurants, noting that 
beginning in July 2019, points would be deducted on inspections for 
selling food products adulterated with CBD.125  One reason that 
health officials are concerned is their belief that it can be difficult for 
customers to differentiate products with and without CBD and the 
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relative dosage in each product.126  Acting under rules created for the 
state’s medical marijuana program, officials from the Ohio 
Department of Agriculture, Health Departments, and Policy have 
visited stores and instructed them to stop selling CBD products or 
risk having them seized.127  The state’s law prohibits the sale of CBD 
except in a licensed dispensary.128   
Despite the de-scheduling of hemp, there can still be a stigma 
associated with the consumption of hemp products.  Consumers of 
untested products also run the risk of testing positively for THC if 
they are drug-tested, which can lead to serious consequences, 
especially for work-related drug testing.129  Some evidence shows 
that consuming large amounts of CBD can yield a false positive.130  
One expert in cannabis testing has clarified that most drug tests are 
designed for finding THC, not other cannabinoids.131  This is an 
extremely discrete issue related to CBD consumption, so most people 
would be better off locating information related to their specific 
situation rather than relying on anecdotal information online. 
V.  Why should the FDA make rules for CBD? 
The CBD market is not slowing down, and full 
implementation of the 2018 Farm Bill is likely to expand it.  The 
FDA needs to make rules for consumer safety and to allow the 
regulated creation of new drugs.  The FDA can create rules for testing 
products, creating a guarantee that a product is CBD, verifying the 
levels of THC, and confirming product purity.132  Access to quality 
CBD products will also assist researchers, who can conduct approved 
trials for new drugs and therapies that use CBD.  Researchers at 
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Johns Hopkins University are planning a clinical trial that will test 
the potential benefits of CBD for smoking cessation.133   
Many potential benefits have been advertised, but not as 
much focus has been put on the side effects.  The listed side effects 
of Epidiolex can include: decreased appetite, diarrhea, rashes, and 
lower sleep quality.134  Consumers also need guidance on dosing and 
the variety of ingestion methods that could change the effectiveness 
of a CBD drug.  Research into CBD could also yield information 
about other cannabinoids and a new understanding of the ensemble 
effect in cannabinoids.   
   It is possible for research to be conducted with synthetic 
cannabinoids.135  The FDA-approved, cannabis-related drugs rely on 
synthetic cannabinoids.136  More recently, yeast has been used to 
produce synthetic THC and CBD.137  The obvious benefits are for 
companies that want to begin research without cultivating hemp and 
also ensure that the CBD is uncontaminated by THC.  There is also 
an opportunity to produce other synthetic cannabinoids and begin to 
understand how many there actually are, potentially with more 
benefits than what we are already aware of.138  If synthetic CBD were 
marketed, though, regulators would do right by consumers by 
requiring a new name for the synthetic chemical, or a clear label that 
indicates it is not a naturally-derived product.   
VI.  How should CBD be treated?  
Regulators have many options for designing CBD rules.  The 
most formal process, and what would allow the most public input, 
would be agency rulemaking.  However, the agency could, through 
rulemaking, use its discretion to allow the use of CBD in food 
products and supplements, despite it not being used in either of these 
products prior to the approval of Epidiolex.  It also seems likely that 
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there will be more research on the therapeutic value of CBD, so 
Epidiolex will not be the only drug on the market for very long.  
In addition to his comments supporting Congressional action 
on the regulation, Gottlieb envisioned it as a tier or schedule of 
concentrations for different products containing CBD, in part 
because the side effects at different concentrations are not yet studied 
and understood.139  Congress could authorize the use in food and 
supplements and then direct the FDA to establish the acceptable 
thresholds for each product.140  The collaboration between Congress 
and the agency is not uncommon and would be the fastest way to 
reach at least a temporary resolution until the FDA can solidify rules.  
Gottlieb also believes that the committee will have recommendations 
by the summer,141 which would be prior to the full 2018 Farm Bill 
implementation.  If producers of CBD products have a better idea of 
their legality, it will also give farmers some clarity on the market for 
hemp.         
VII.  Conclusion  
CBD has captured the interest of many different groups and 
created a headache for federal and state agencies.  This is an exciting 
product, simply because of its untapped potential.  It is, of course, 
added to the long list of useful hemp products, providing farmers 
with a new way to use their crops.  The FDA and Congress should 
work together to create rules that allow food and drug producers to 
each have a piece of the market and provide consumers with tools for 
health and overall wellness.    
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